Invesco Biotechnology & Genome ETF PBE
99.20 USD -5.47 (-5.23%)
Nov 5, 2026, 3:59 PM EST
99.11 Day range 103.10
75.10 52-week range 104.69
- YTD
- +20.75%
- 1 year
- +29.23%
- Market cap
- 302.43M
- EPS (ttm)
- 3.92
- P/E ratio
- 25.30
- YTD return
- +20.75%
- 1-year return
- +29.23%
- Volume
- 10.54K
- Avg volume
- 18.32K
- Open
- 103.30
- Previous close
- 104.67
- Day's range
- 99.11 – 103.10
- 52-week range
- 75.10 – 104.69
15m -4.96 (-4.76%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 69.17
- 200-day average
- 67.04
About Invesco Biotechnology & Genome ETF
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.
News
Cathie Wood Loads Up On Biotech: 5 ETFs Holding Her Latest Bets 
Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention 
Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules 
Exclusive: SunTrust Managing Director Discusses Bluebird Bio, A Leader In Gene Therapy 
Interesting Similarities Among 2013's Top-Performing ETFs - The Definitive Biotech ETF Guide (IBB, XBI, FBT)
Your note
Sign in to keep a note on PBE — it syncs with the Stock Master app.